BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Find the Wonders of the Silk Street: Following the Antiquated Shipping lanes - 2Scientists find new clues to why female fertility declines with age
- 3Barry Manilow to have surgery for early-stage lung cancer and postpones January concerts
- 4Audits of 6 American Busssiness Class Flights
- 5Midlife weight gain can start long before menopause – but you can take steps early on to help your body weather the hormonal shift
- How a Snake That Eats Cobras Redefined the Meaning of ‘King’
- Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
- 5 Fundamental Ways to employ a Criminal Legal counselor
- Discovery of massive spider's web in Greece reveals unexpected behavior
- PFAS in pregnant women’s drinking water puts their babies at higher risk, study finds
- Astronauts welcome arrival of new crewmates | On the International Space Station this week Nov. 24-28, 2025
- 'Home Alone' actor Joe Pesci said 'no' to this stunt until he saw a 9-year-old girl do it, says director Chris Columbus
- Which Film Has the Incomparable Melodic Score?
- Vote In favor of Your Favored Distributed computing Administration
